Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 63

1.

MicroRNA-132 provides neuroprotection for tauopathies via multiple signaling pathways.

El Fatimy R, Li S, Chen Z, Mushannen T, Gongala S, Wei Z, Balu DT, Rabinovsky R, Cantlon A, Elkhal A, Selkoe DJ, Sonntag KC, Walsh DM, Krichevsky AM.

Acta Neuropathol. 2018 Oct;136(4):537-555. doi: 10.1007/s00401-018-1880-5. Epub 2018 Jul 7.

2.

Pluripotent stem cell-based therapy for Parkinson's disease: Current status and future prospects.

Sonntag KC, Song B, Lee N, Jung JH, Cha Y, Leblanc P, Neff C, Kong SW, Carter BS, Schweitzer J, Kim KS.

Prog Neurobiol. 2018 Sep;168:1-20. doi: 10.1016/j.pneurobio.2018.04.005. Epub 2018 Apr 11. Review.

PMID:
29653250
3.

Gene expression profile associated with postnatal development of pyramidal neurons in the human prefrontal cortex implicates ubiquitin ligase E3 in the pathophysiology of schizophrenia onset.

Kohlbrenner EA, Shaskan N, Pietersen CY, Sonntag KC, Woo TW.

J Psychiatr Res. 2018 Jul;102:110-117. doi: 10.1016/j.jpsychires.2018.03.013. Epub 2018 Apr 3.

PMID:
29635114
4.

Laser microdissection and gene expression profiling in the human postmortem brain.

Sonntag KC, Woo TW.

Handb Clin Neurol. 2018;150:263-272. doi: 10.1016/B978-0-444-63639-3.00018-9.

PMID:
29496145
5.

Cell Type-Specific Laser Capture Microdissection for Gene Expression Profiling in the Human Brain.

Mauney SA, Woo TW, Sonntag KC.

Methods Mol Biol. 2018;1723:203-221. doi: 10.1007/978-1-4939-7558-7_11.

PMID:
29344862
6.

Late-onset Alzheimer's disease is associated with inherent changes in bioenergetics profiles.

Sonntag KC, Ryu WI, Amirault KM, Healy RA, Siegel AJ, McPhie DL, Forester B, Cohen BM.

Sci Rep. 2017 Oct 25;7(1):14038. doi: 10.1038/s41598-017-14420-x.

7.

Dicer and microRNAs protect adult dopamine neurons.

Chmielarz P, Konovalova J, Najam SS, Alter H, Piepponen TP, Erfle H, Sonntag KC, Schütz G, Vinnikov IA, Domanskyi A.

Cell Death Dis. 2017 May 25;8(5):e2813. doi: 10.1038/cddis.2017.214.

8.

Erratum to "Preventative treatment in an animal model of DHD: Behavioral and biochemical effects of methylphenidate and its interactions with ovarian hormones in female rats" [Eur. Neuropsychopharmacol. 26 (2016) 1496-1506].

Lukkes JL, Sonntag KC, Freund N, Thompson BS, Meda S, Andersen SL.

Eur Neuropsychopharmacol. 2016 Nov;26(11):1843. doi: 10.1016/j.euroneuro.2016.10.001. Epub 2016 Oct 28. No abstract available.

PMID:
28236417
9.

Limited predictability of postmortem human brain tissue quality by RNA integrity numbers.

Sonntag KC, Tejada G, Subburaju S, Berretta S, Benes FM, Woo TU.

J Neurochem. 2016 Jul;138(1):53-9. doi: 10.1111/jnc.13637. Epub 2016 May 12.

10.

Differentiation of oligodendrocyte precursors is impaired in the prefrontal cortex in schizophrenia.

Mauney SA, Pietersen CY, Sonntag KC, Woo TW.

Schizophr Res. 2015 Dec;169(1-3):374-380. doi: 10.1016/j.schres.2015.10.042. Epub 2015 Nov 14.

11.

Midbrain dopamine neurons in Parkinson's disease exhibit a dysregulated miRNA and target-gene network.

Briggs CE, Wang Y, Kong B, Woo TU, Iyer LK, Sonntag KC.

Brain Res. 2015 Aug 27;1618:111-21. doi: 10.1016/j.brainres.2015.05.021. Epub 2015 Jun 3.

12.

Extinction and reinstatement to cocaine-associated cues in male and female juvenile rats and the role of D1 dopamine receptor.

Brenhouse HC, Thompson BS, Sonntag KC, Andersen SL.

Neuropharmacology. 2015 Aug;95:22-8. doi: 10.1016/j.neuropharm.2015.02.017. Epub 2015 Mar 4.

13.

Evidence against dopamine D1/D2 receptor heteromers.

Frederick AL, Yano H, Trifilieff P, Vishwasrao HD, Biezonski D, Mészáros J, Urizar E, Sibley DR, Kellendonk C, Sonntag KC, Graham DL, Colbran RJ, Stanwood GD, Javitch JA.

Mol Psychiatry. 2015 Nov;20(11):1373-85. doi: 10.1038/mp.2014.166. Epub 2015 Jan 6.

14.

Fast and efficient neural conversion of human hematopoietic cells.

Castaño J, Menendez P, Bruzos-Cidon C, Straccia M, Sousa A, Zabaleta L, Vazquez N, Zubiarrain A, Sonntag KC, Ugedo L, Carvajal-Vergara X, Canals JM, Torrecilla M, Sanchez-Pernaute R, Giorgetti A.

Stem Cell Reports. 2014 Dec 9;3(6):1118-31. doi: 10.1016/j.stemcr.2014.10.008. Epub 2014 Nov 13.

15.

MiR-126 Regulates Growth Factor Activities and Vulnerability to Toxic Insult in Neurons.

Kim W, Noh H, Lee Y, Jeon J, Shanmugavadivu A, McPhie DL, Kim KS, Cohen BM, Seo H, Sonntag KC.

Mol Neurobiol. 2016 Jan;53(1):95-108. doi: 10.1007/s12035-014-8989-x. Epub 2014 Nov 19.

16.

Selection Based on FOXA2 Expression Is Not Sufficient to Enrich for Dopamine Neurons From Human Pluripotent Stem Cells.

Aguila JC, Blak A, van Arensbergen J, Sousa A, Vázquez N, Aduriz A, Gayosso M, Lopez Mato MP, Lopez de Maturana R, Hedlund E, Sonntag KC, Sanchez-Pernaute R.

Stem Cells Transl Med. 2014 Sep;3(9):1032-42. doi: 10.5966/sctm.2014-0011. Epub 2014 Jul 14.

17.

Molecular profiles of pyramidal neurons in the superior temporal cortex in schizophrenia.

Pietersen CY, Mauney SA, Kim SS, Lim MP, Rooney RJ, Goldstein JM, Petryshen TL, Seidman LJ, Shenton ME, McCarley RW, Sonntag KC, Woo TU.

J Neurogenet. 2014 Mar-Jun;28(1-2):53-69. doi: 10.3109/01677063.2014.882918. Epub 2014 Apr 10.

18.

Molecular profiles of parvalbumin-immunoreactive neurons in the superior temporal cortex in schizophrenia.

Pietersen CY, Mauney SA, Kim SS, Passeri E, Lim MP, Rooney RJ, Goldstein JM, Petreyshen TL, Seidman LJ, Shenton ME, Mccarley RW, Sonntag KC, Woo TU.

J Neurogenet. 2014 Mar-Jun;28(1-2):70-85. doi: 10.3109/01677063.2013.878339. Epub 2014 Mar 17.

19.

miR-126 contributes to Parkinson's disease by dysregulating the insulin-like growth factor/phosphoinositide 3-kinase signaling.

Kim W, Lee Y, McKenna ND, Yi M, Simunovic F, Wang Y, Kong B, Rooney RJ, Seo H, Stephens RM, Sonntag KC.

Neurobiol Aging. 2014 Jul;35(7):1712-21. doi: 10.1016/j.neurobiolaging.2014.01.021. Epub 2014 Jan 24.

20.

Juvenile methylphenidate reduces prefrontal cortex plasticity via D3 receptor and BDNF in adulthood.

Andersen SL, Sonntag KC.

Front Synaptic Neurosci. 2014 Jan 21;6:1. doi: 10.3389/fnsyn.2014.00001. eCollection 2014.

21.

Viral over-expression of D1 dopamine receptors in the prefrontal cortex increase high-risk behaviors in adults: comparison with adolescents.

Sonntag KC, Brenhouse HC, Freund N, Thompson BS, Puhl M, Andersen SL.

Psychopharmacology (Berl). 2014 Apr;231(8):1615-26. doi: 10.1007/s00213-013-3399-8. Epub 2014 Jan 10.

22.

Part-human animal research: the imperative to move beyond a philosophical debate.

Abelman M, O'Rourke PP, Sonntag KC.

Am J Bioeth. 2012;12(9):26-8. doi: 10.1080/15265161.2012.699155. No abstract available.

PMID:
22881849
23.

Detection of intranasally delivered bone marrow-derived mesenchymal stromal cells in the lesioned mouse brain: a cautionary report.

Chartoff EH, Damez-Werno D, Sonntag KC, Hassinger L, Kaufmann DE, Peterson J, McPhie D, Cataldo AM, Cohen BM.

Stem Cells Int. 2011;2011:586586. doi: 10.4061/2011/586586. Epub 2011 Nov 15.

24.

Converging miRNA functions in diverse brain disorders: a case for miR-124 and miR-126.

Sonntag KC, Woo TU, Krichevsky AM.

Exp Neurol. 2012 Jun;235(2):427-35. doi: 10.1016/j.expneurol.2011.11.035. Epub 2011 Dec 8. Review.

25.

Neuronal type-specific gene expression profiling and laser-capture microdissection.

Pietersen CY, Lim MP, Macey L, Woo TU, Sonntag KC.

Methods Mol Biol. 2011;755:327-43. doi: 10.1007/978-1-61779-163-5_28.

26.

A novel, multiple symptom model of obsessive-compulsive-like behaviors in animals.

Andersen SL, Greene-Colozzi EA, Sonntag KC.

Biol Psychiatry. 2010 Oct 15;68(8):741-7. doi: 10.1016/j.biopsych.2010.05.011.

PMID:
20619828
27.

RNA mechanisms in CNS systems and disorders.

Sonntag KC, Wahlestedt C.

Brain Res. 2010 Jun 18;1338:1-2. doi: 10.1016/j.brainres.2010.04.007. Epub 2010 Apr 7. No abstract available.

PMID:
20380824
28.

MicroRNAs and deregulated gene expression networks in neurodegeneration.

Sonntag KC.

Brain Res. 2010 Jun 18;1338:48-57. doi: 10.1016/j.brainres.2010.03.106. Epub 2010 Apr 7. Review.

29.

Evidence for gender-specific transcriptional profiles of nigral dopamine neurons in Parkinson disease.

Simunovic F, Yi M, Wang Y, Stephens R, Sonntag KC.

PLoS One. 2010 Jan 25;5(1):e8856. doi: 10.1371/journal.pone.0008856.

30.

Stem cells and cell replacement therapy for Parkinson's disease.

Sonntag KC, Simunovic F, Sanchez-Pernaute R.

J Neural Transm Suppl. 2009;(73):287-99.

PMID:
20411787
31.

Gene expression profiling of substantia nigra dopamine neurons: further insights into Parkinson's disease pathology.

Simunovic F, Yi M, Wang Y, Macey L, Brown LT, Krichevsky AM, Andersen SL, Stephens RM, Benes FM, Sonntag KC.

Brain. 2009 Jul;132(Pt 7):1795-809. doi: 10.1093/brain/awn323. Epub 2008 Dec 3.

32.

ES cell-derived neuroepithelial cell cultures.

Karki S, Pruszak J, Isacson O, Sonntag KC.

J Vis Exp. 2006 Nov 30;(1):118. doi: 10.3791/118.

33.

Parthenogenetic dopamine neurons from primate embryonic stem cells restore function in experimental Parkinson's disease.

Sanchez-Pernaute R, Lee H, Patterson M, Reske-Nielsen C, Yoshizaki T, Sonntag KC, Studer L, Isacson O.

Brain. 2008 Aug;131(Pt 8):2127-39. doi: 10.1093/brain/awn144. Epub 2008 Jul 22.

34.

Juvenile methylphenidate modulates reward-related behaviors and cerebral blood flow by decreasing cortical D3 receptors.

Andersen SL, Napierata L, Brenhouse HC, Sonntag KC.

Eur J Neurosci. 2008 Jun;27(11):2962-72. doi: 10.1111/j.1460-9568.2008.06254.x.

PMID:
18588536
35.

Transient D1 dopamine receptor expression on prefrontal cortex projection neurons: relationship to enhanced motivational salience of drug cues in adolescence.

Brenhouse HC, Sonntag KC, Andersen SL.

J Neurosci. 2008 Mar 5;28(10):2375-82. doi: 10.1523/JNEUROSCI.5064-07.2008.

36.

Immature and neurally differentiated mouse embryonic stem cells do not express a functional Fas/Fas ligand system.

Brunlid G, Pruszak J, Holmes B, Isacson O, Sonntag KC.

Stem Cells. 2007 Oct;25(10):2551-8. Epub 2007 Jul 5.

37.

Markers and methods for cell sorting of human embryonic stem cell-derived neural cell populations.

Pruszak J, Sonntag KC, Aung MH, Sanchez-Pernaute R, Isacson O.

Stem Cells. 2007 Sep;25(9):2257-68. Epub 2007 Jun 21.

38.

Proteasome activator enhances survival of Huntington's disease neuronal model cells.

Seo H, Sonntag KC, Kim W, Cattaneo E, Isacson O.

PLoS One. 2007 Feb 28;2(2):e238.

39.

Enhanced yield of neuroepithelial precursors and midbrain-like dopaminergic neurons from human embryonic stem cells using the bone morphogenic protein antagonist noggin.

Sonntag KC, Pruszak J, Yoshizaki T, van Arensbergen J, Sanchez-Pernaute R, Isacson O.

Stem Cells. 2007 Feb;25(2):411-8. Epub 2006 Oct 12.

40.

Tailoring human embryonic stem cells for neurodegenerative disease therapy.

Sonntag KC, Sanchez-Pernaute R.

Curr Opin Investig Drugs. 2006 Jul;7(7):614-8. Review.

PMID:
16869113
41.

Specific microRNAs modulate embryonic stem cell-derived neurogenesis.

Krichevsky AM, Sonntag KC, Isacson O, Kosik KS.

Stem Cells. 2006 Apr;24(4):857-64. Epub 2005 Dec 15.

42.

Implementations of translational medicine.

Sonntag KC.

J Transl Med. 2005 Aug 30;3:33.

43.

Cell type-specific gene expression of midbrain dopaminergic neurons reveals molecules involved in their vulnerability and protection.

Chung CY, Seo H, Sonntag KC, Brooks A, Lin L, Isacson O.

Hum Mol Genet. 2005 Jul 1;14(13):1709-25. Epub 2005 May 11.

44.

Stem cells may reshape the prospect of Parkinson's disease therapy.

Sonntag KC, Simantov R, Isacson O.

Brain Res Mol Brain Res. 2005 Mar 24;134(1):34-51. Review.

PMID:
15790528
45.

Context-dependent neuronal differentiation and germ layer induction of Smad4-/- and Cripto-/- embryonic stem cells.

Sonntag KC, Simantov R, Björklund L, Cooper O, Pruszak J, Kowalke F, Gilmartin J, Ding J, Hu YP, Shen MM, Isacson O.

Mol Cell Neurosci. 2005 Mar;28(3):417-29.

PMID:
15737733
46.

Generalized brain and skin proteasome inhibition in Huntington's disease.

Seo H, Sonntag KC, Isacson O.

Ann Neurol. 2004 Sep;56(3):319-28.

PMID:
15349858
47.

Temporally induced Nurr1 can induce a non-neuronal dopaminergic cell type in embryonic stem cell differentiation.

Sonntag KC, Simantov R, Kim KS, Isacson O.

Eur J Neurosci. 2004 Mar;19(5):1141-52.

48.

Human Fas-ligand expression on porcine endothelial cells does not protect against xenogeneic natural killer cytotoxicity.

Matter-Reissmann UB, Sonntag KC, Gilli UO, Leguern C, Schneider MK, Seebach JD.

Xenotransplantation. 2004 Jan;11(1):43-52.

PMID:
14962292
49.

Genetic engineering of mouse embryonic stem cells by Nurr1 enhances differentiation and maturation into dopaminergic neurons.

Chung S, Sonntag KC, Andersson T, Bjorklund LM, Park JJ, Kim DW, Kang UJ, Isacson O, Kim KS.

Eur J Neurosci. 2002 Nov;16(10):1829-38.

50.

Analysis of different promoter systems for efficient transgene expression in mouse embryonic stem cell lines.

Chung S, Andersson T, Sonntag KC, Björklund L, Isacson O, Kim KS.

Stem Cells. 2002;20(2):139-45.

Supplemental Content

Loading ...
Support Center